Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Clinical Investigation

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI117251PMID 8200978PMCID PMC294451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in the extracellular matrix components in human glomerular diseases

  2004cited by this paper
• Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients

  1993cited by this paper
• Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations.

  1993cited by this paper
• Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.

  1993cited by this paper
• Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.

  1993cited by this paper
• Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

  1993cited by this paper
• Angiotensin II as a renal growth factor.

  1993cited by this paper
• Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

  1993cited by this paper
• Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.

  1993cited by this paper
• Extracellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis.

  1993cited by this paper
• Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

  1993cited by this paper
• Angiotensin II causes mesangial cell hypertrophy.

  1993cited by this paper
• Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat.

  1992cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.

  1992cited by this paper
• Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity

  1992cited by this paper
• Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.

  1992cited by this paper
• Glomerular matrix accumulation is linked to inhibition of the plasmin protease system.

  1992cited by this paper
• Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure.

  1992cited by this paper
• Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells.

  1992cited by this paper
• High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta.

  1992cited by this paper
• The pathobiology of the mesangium.

  1992cited by this paper
• Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

  1992cited by this paper
• Glomerular hypertrophy accelerates hypertensive glomerular injury in rats.

  1991cited by this paper
• Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.

  1991cited by this paper
• Angiotensin actions in the kidney: renewed insight into the old hormone.

  1991cited by this paper
• Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

  1990cited by this paper
• Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

  1990cited by this paper
• Influence of the angiotensin system on endothelial and smooth muscle cell migration.

  1990cited by this paper
• Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.

  1990cited by this paper
• Transforming growth factor-beta regulates production of proteoglycans by mesangial cells.

  1990cited by this paper
• Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.

  1990cited by this paper
• Effect of dietary protein on rat renin and angiotensinogen gene expression.

  1990cited by this paper
• Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells.

  1990cited by this paper
• The progression of renal disease.

  1989cited by this paper
• Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions.

  1989cited by this paper
• Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Effects of antihypertensive drugs on glomerular morphology.

  1989cited by this paper
• Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells.

  1989cited by this paper
• Progression of renal disease.

  1989cited by this paper
• Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species.

  1989cited by this paper
• Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

  1988cited by this paper
• Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.

  1988cited by this paper
• The glomerular mesangial cell: an expanding role for a specialized pericyte

  1987cited by this paper
• The murine transforming growth factor-beta precursor.

  1986cited by this paper
• Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

  1985cited by this paper
• Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

  1985cited by this paper
• Angiotensin II in adrenergic-induced alterations in glomerular hemodynamics.

  1984cited by this paper
• Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D.

  1984cited by this paper
• Title Glomerulosclerosis Induced by in vivo Transfection of transforming Growth Factor-β or Platelet-derived Growth Factor Gene into the Rat Kidney

  year unknowncited by this paper

• Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology.

  2026cites this paper
• Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy

  2025cites this paper
• A review of the phytochemical and pharmacological properties of FlosLoniceraeJaponicae in treating obesity and type 2 diabetes mellitus: a medicinal and edible plant

  2025cites this paper
• Transforming growth factor-beta (TGF-β) in the pathogenesis of hereditary thoracic aneurysm disorders.

  2025cites this paper
• Multifaceted roles of Epac signaling in renal functions

  2025cites this paper
• Molecular mechanisms and therapeutic interventions in acute kidney injury: a literature review

  2025cites this paper
• The Role of Renin-Angiotensin System in Diabetic Nephropathy: An Update.

  2025cites this paper
• Mathematical modeling of impacts of patient differences on renin-angiotensin system and applications to COVID-19 lung fibrosis outcomes

  2025cites this paper
• Immunology of Hypertension: Pathophysiological and Therapeutic Aspects

  2025cites this paper
• Association Between Hypertension, Dipping Status, and ACE and AGTR1 Gene Polymorphisms in Adolescents with Type 1 Diabetes

  2025cites this paper
• Multi‐Parametric MRI for Early Detection of Renal Fibrosis and Evaluation of Therapeutic Effect of Asiatic Acid in an Experimental Rat

  2025cites this paper
• First Description of Sprue-Like Enteropathy due to Azilsartan: A Case Report

  2025cites this paper
• Renal dysplasia development and chronic kidney disease

  2025cites this paper
• Determination of both the expression and serum levels of epidermal growth factor and transforming growth factor β1 genes in COVID-19

  2025cites this paper
• Nephrectomy Induces Severe Bone Loss in Mice Expressing Constitutively Active TGFβ Receptor Type I

  2025cites this paper
• Molecular Basis of Chronic Intestinal Wall Fibrosis in Inflammatory Bowel Diseases

  2025cites this paper
• Personalized Medicine in Cardiovascular Pharmacology: Advances in Pharmacogenomics and Drug Development

  2025cites this paper
• Critical role of Gα12 and Gα13 proteins in TGF-β-induced myofibroblast differentiation

  2024cites this paper
• Molecular Features of Calcific Aortic Stenosis in Female and Male Patients

  2024cites this paper
• Plasma Biomarker Screening Based on Proteomic Signature of Patients with Resistant Hypertension

  2024cites this paper
• Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice.

  2024cites this paper
• Gα12 and Gα13 proteins are required for transforming growth factor-β-induced myofibroblast differentiation

  2024cites this paper
• Elucidating the complex interplay between chronic kidney disease and hypertension

  2024cites this paper
• Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy

  2024cites this paper
• Research Progress of Triptolide Against Fibrosis

  2024cites this paper
• Tetra-ARMS PCR analysis of angiotensinogen AGT T174M (rs4762) genetic polymorphism in diabetic patients: a comprehensive study

  2023cites this paper
• The role of fibrosis in the pathophysiology of muscular dystrophy.

  2023cites this paper
• Time to eRAASe chronic inflammation: current advances and future perspectives on renin-angiotensin-aldosterone-system and chronic intestinal inflammation in dogs and humans

  2023cites this paper
• Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis

  2023cites this paper
• Drug-Induced Gingival Overgrowth—Molecular Aspects of Drug Actions

  2023cites this paper
• Advances in targeting the extracellular matrix for glaucoma therapy: current updates

  2023cites this paper
• Evaluation of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Renal Allograft Biopsies:- Comparison of Visual Analysis with Morphometric Quantification and its Correlation with Renal Function

  2023cites this paper
• Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors

  2023cites this paper
• Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation

  2022cites this paper
• The modulatory effect of sodium molybdate against cisplatin-induced CKD: Role of TGF-β/Smad signaling pathway.

  2022cites this paper
• Olmesartan-induced sprue-like enteropathy

  2022cites this paper
• Role of angiotensin II in aging

  2022cites this paper
• Cardiac fibrosis in oncologic therapies.

  2022cites this paper
• The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications

  2022cites this paper
• The Mechanistic Role of Different Mediators in the Pathophysiology of Nephropathy: A Review.

  2022cites this paper
• Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease

  2022cites this paper
• Activation of Mast-Cell-Derived Chymase in the Lacrimal Glands of Patients with IgG4-Related Ophthalmic Disease

  2022cites this paper
• The Glomerulus According to the Mesangium

  2022cites this paper
• Mathematical Modeling of Impacts of Patient Differences on Renin-Angiotensin System and Applications to COVID-19 Lung Fibrosis Outcomes

  2022cites this paper
• Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction

  2022cites this paper
• The Diabetic Cardiorenal Nexus

  2022cites this paper
• Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms.

  2021cites this paper
• Intratubular, Intracellular, and Mitochondrial Angiotensin II/AT1 (AT1a) Receptor/NHE3 Signaling Plays a Critical Role in Angiotensin II-Induced Hypertension and Kidney Injury

  2021cites this paper
• The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney

  2021cites this paper
• Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease

  2021influential citation
• Diabetes and Renin-Angiotensin-Aldosterone System: Pathophysiology and Genetics

  2021cites this paper
• Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis

  2021cites this paper
• Emphysema progression and lung function decline among angiotensin converting enzyme inhibitors (ACEi) and angiotensin-receptor blockade (ARB) users in the COPDGene® Cohort.

  2021cites this paper
• Understanding the Renal Fibrotic Process in Leptospirosis

  2021cites this paper
• Protective effect of alamandine on doxorubicin‑induced nephrotoxicity in rats

  2021cites this paper
• Clitoria ternatea L. extract prevents kidney damage by suppressing the Ang II/Nox4/oxidative stress cascade in L-NAME-induced hypertension model of rats.

  2021cites this paper
• Vascular Basement Membrane Thickening: Basis of Disease Pathology in Diabetic Retinopathy

  2021cites this paper
• Sex Differences in Angiotensin II-Induced Hypertension and Kidney Injury: Role of AT1a Receptors in The Proximal Tubule of The Kidney.

  2021cites this paper
• Angiotensinogen Gene Missense Polymorphisms (rs699 and rs4762): The Association of End-Stage Renal Failure Risk with Type 2 Diabetes and Hypertension in Egyptians

  2021cites this paper
• Klotho supplementation attenuates blood pressure and albuminuria in murine model of IgA nephropathy

  2021cites this paper
• Renin-Angiotensin System Induced Secondary Hypertension: The Alteration of Kidney Function and Structure

  2021cites this paper
• Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases

  2021cites this paper
• The renin-angiotensin system in pediatric kidney disease: from pathophysiology to the novel therapeutic approach

  2021cites this paper
• Insights on the Pathogenesis of Aneurysm through the Study of Hereditary Aortopathies

  2021cites this paper
• Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences

  2021cites this paper
• Assessing and Counteracting Fibrosis is a Cornerstone of the Treatment of CKD Secondary to Systemic and Renal Limited Autoimmune Disorders.

  2021cites this paper
• Kidney Allograft Fibrosis: Diagnostic and Therapeutic Strategies

  2021cites this paper
• The red flags of ulnar neuropathy in leprosy

  2021cites this paper
• COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis

  2021cites this paper
• Treatment of Diabetic Kidney Disease: Current and Future

  2021cites this paper
• Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes

  2021influential citation
• SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis

  2020cites this paper
• TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression

  2020cites this paper
• Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma

  2020cites this paper
• Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis

  2020cites this paper
• Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.

  2020cites this paper
• World Journal of Gastroenterology From to of via the gut-liver-brain axis in

  2020cites this paper
• Tandospirone enhances the anti-myocardial fibrosis effect of valsartan in spontaneously hypertensive rats.

  2020cites this paper
• Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome

  2020cites this paper
• Mesangioproliferative glomerulonephritis with extracapillary crescents – unexpected fatal complication in a 17-year-old patient with implanted left ventricular assist device

  2020influential citation
• Neurotransmitters and Their Receptors—State of the Art

  2020cites this paper
• Up-regulation of PKR pathway contributes to L-NAME induced hypertension and renal damage

  2020influential citation
• The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease

  2020cites this paper
• Tumor Microenvironment: Molecular Players – Part B

  2020cites this paper
• Targeting the Renin-Angiotensin-Aldosterone System in Fibrosis.

  2020cites this paper
• Renin-Angiotensin System in the Tumor Microenvironment.

  2020cites this paper
• Pathogenesis of Microvascular Complications

  2020cites this paper
• Cardiac fibrosis.

  2020cites this paper
• Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

  2020cites this paper
• Alterations in Lipid Profile of the Aging Kidney Identified by MALDI Imaging Mass Spectrometry.

  2019cites this paper
• The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells

  2019cites this paper
• Fibroblasts in the Infarcted, Remodeling, and Failing Heart

  2019cites this paper
• Inflammation in thoracic aortic aneurysms

  2019cites this paper
• Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?

  2019cites this paper
• Le rôle de la protéine interagissant avec hedgehog (Hhip) dans la formation rénale modulée par le diabète maternel et dans la néphropathie diabétique

  2019cites this paper
• The Effect of Quercetin for Salt Induces Renal Fibrosis by Suppressing Collagen Production

  2019cites this paper
• Stimulating Type 1 Angiotensin Receptors on T Lymphocytes Attenuates Renal Fibrosis.

  2019influential citation
• A comparative analysis of the molecular basis of fibrosis between tissues

  2019influential citation
• Association between TGF-β1 -913G/C polymorphism and myocardial infarction risk in a Chinese Han population: a case–control study

  2019cites this paper
• КАРДИОРЕНАЛЬНЫЙ СИНДРОМ У БОЛЬНЫХ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ КАК ЭТАП КАРДИОРЕНАЛЬНОГО КОНТИНУУМА (ЧАСТЬ I): ОПРЕДЕЛЕНИЕ, КЛАССИФИКАЦИЯ, ПАТОГЕНЕЗ, ДИАГНОСТИКА, ЭПИДЕМИОЛОГИЯ (ОБЗОР ЛИТЕРАТУРЫ)

  2019cites this paper